Etracs 150% Alerian MLP ETNMLPRETF
13F holders, Q1 2025 (March 31)1holders
1new positions
0sold out
$68.43avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Etracs 150% Alerian MLP ETN (MLPR) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 0 sold out. The largest holder was UBS Group AG ($2K).
- Company
- Etracs 150% Alerian MLP ETN
- Filed as
- UBS AG LONDON BRANCH (Q1 2025)
- CUSIP
- 90269A278
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q1 2025: 30 shares bought, net +30 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | 0.00% | New | 30 | $2K |
"% of holder's portfolio" is MLPR's weight in each manager's 13F, not the share of Etracs 150% Alerian MLP ETN the manager owns.